Tue, Mar 3, 2015, 11:39 AM EST - U.S. Markets close in 4 hrs 21 mins

Recent

% | $
Quotes you view appear here for quick access.

V.I. Technologies, Inc. (VITX) Message Board

  • simplylegen3 simplylegen3 Apr 5, 1999 5:10 AM Flag

    vitx stuff

     

    hey there, I want to pass on this cool new research site. It's pretty well done and free too... http://www.viaduk.net/freepage.nsf/page/jonnie

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • This will come back sooner or later. I bought this stock last year at 5 and 1/2, sold at 9.

      Good Luck,
      Mike

    • From the 4/16/99 company press release, they
      project first quater earnings estimates in line with
      analysit expectations, which should place them at about 5
      cents per share. That is why I bought 2000 shares today
      at 6 and 3/4. Also from the press release, they
      found 2 lots with high B19 PCR parvovirus, which sounds
      relatively benign if over 50% of the people in the US
      already have it in their blood. The press release said
      they are recalilng 7 lots (1 week production) out of
      an abundance of caution, which also sounds OK. The
      press release also stated that they intend to test
      their "production to date" for high levels of B19 PCR
      and assess the need for further product recall. This
      must be the problem, as no sooner did I buy at 6 and
      3/4 then it went immediatley down to 6. Someone is
      panicing, and thus if anyone participates in the conference
      call it would be extremely helpful if we could get
      feedback as to (1) why they are testing for B19 PCR if
      over 50% of the people in the US have it in their
      blood and no other plasma is tested for it, especially
      if it is essentially benign and (2) what are they
      going to do with their production to date if they find
      it in all the lots, as they are likely to find it if
      over 50% of the people already have it? As I undestand
      it, the SD process is not supposed to effect
      non-lipid viruses like B19 PCR -- so it is not surprising
      that such common non-lipid viruses would be found in
      the product. Undoubtedly, it is found in the same
      percentage of the VITX plasma as it is found in normal
      plasma. So can someone tell me what is going on? Why
      should this cause the stock to cave -- is it the word
      "safety recall" itself that is precipitating the
      sell-off, and if in fact there is no genuine need for a
      "safety recall", why is management doing a "safety
      recall" when their product is safer than anything else
      out there? Should all plasma be recalled -- and can
      someone articulate what the cost to the company is going
      to be from all this? What does the board think about
      this selloff and "safety recall", and if someone
      listens to the conference call, will they post what
      management says about all this? Thanks.

    • I believe I recall VITX saying that EPS would be
      released this Tuesday. Target is to beat $.05.

      In
      the afternoon, VITX will hold a conference call. I
      strongly urge all serious investors to attend the call.
      you must call Debbie Bailey to get the
      number(516-752-7314, ask for investor relations).

      VITX's web
      site is not ready but will have the address
      www.vitxtechnologies.com

      I don't expect any major EPS news (in the 1st qtr)
      but I hope we can show continued improvement to lift
      the stock price to a respectable level. The late
      Friday selloff was only a couple of hundred shares ( I
      know because my buy order only was partially filled at
      7 1/4).

      Interesting questions that I hope
      are asked:

      1. When will revenue begin from
      additional fractionization?
      2. Status on sales effort of
      Plasma?
      3. In which quarter will we see major
      impact?
      4. When will Plasma disclaimer in SEC reports be
      removed? (the one that keeps saying sales are slower than
      anticpated)
      5. Status on Fibrin Phase III trials?
      6.
      Universal Plasma-NDA when and what is the economic
      impact?
      7. Management plans on increasing shareholder
      value?
      8. When will first milestone on red cells with PALL
      be met?
      9. Date for new web site?
      10. Analyst
      est. why the major jump in 3 rd qtr..will we make
      it?
      11. Insurance lawsuit..status and the income effect
      if favorable?


      Again, please attend the
      conference call, and always be careful.

    • The purpose of this post is to inform you of an
      emerging Internet company, NASDAQ:TPEG, soon to be
      "Internet and Technology Resources" Corporation
      (NASDAQ:IATR).

      TPEG began their transition into the Internet business
      approximately ninety days ago and are following a model similar
      to CMGI and WCAP. All the below FACTS detail their
      progress and can be verified by one of two ways:

      1)
      By reviewing the company Press Releases over the
      last three months:
      http://biz.yahoo.com/n/t/tpeg.html

      2) By calling Strategic Capital Consultants (IR) @
      323-936-2855

      In addition, a TPEG(IATR) chat room was created last
      month to discuss the developments of TPEG. Feel free to
      visit that room and ask any questions as they relate to
      the
      stock:http://clubs.yahoo.com/clubs/duedilligence

      Or visit the Yahoo message Board
      at
      http://post.messages.yahoo.com/?action=q&board=tpeg#listhref

      TPEG (IATR) Facts:

      1) On January 20, 1999, TPEG
      formally announced a corporate restructuring plan to
      redirect its business from the movie production industry
      to the internet / e-commerce industry.

      2) On
      February 4, 1999, TPEG announced the purchase of a
      significant equity position in flowersandgifts.com. The
      flowersandgifts.com private placement ends 4-15-99 and an IPO follows
      shortly. Their website can be found at:
      http://www.flowersandgifts.com.

      3) On February 25, 1999, TPEG announced the purchase
      of a significant equity position in Pacific
      Softworks. Their web site can be found at:
      http://www.pacificsw.com.

      4) On March 1, 1999, TPEG announced that it will
      change its name to "Internet and Technology Resources"
      (IATR). The name change and cusip change will go into
      effect immediately after the shareholder's meeting in
      late May 1999.

    • I am new to this board.

      What is VITX's
      long-term business outlook?

      Are there any current
      earnings estimates for this fiscal year?

      Is
      competiting technology a concern for this company? Could
      someone come out with a cheaper alternative such as a
      cheap way to test for AIDS, Hepatitis, etc (then the
      blood could be simply discarded and no blood would
      actually need to be "treated").

      • 1 Reply to xlilly
      • <<Is competiting technology a concern for
        this company? Could someone come out with a cheaper
        alternative
        such as a cheap way to test for AIDS, Hepatitis,
        etc (then the blood could be simply discarded and no
        blood
        would actually need to be "treated").
        >>

        I would presume that there are many companies that
        have made assay products for such viruses. As for
        their cost, that may be expensive but I am not sure how
        much a treatment for the VITX product costs. I would
        think that much of this may depend on analysis time.
        Many assays take some time for the chemical to
        register the existance of the virus. Such time cost and
        labor cost of looking over each container of blood may
        be very costly compared to VITX's treatment (I am
        not sure about this).

        The other point that
        was mentioned in a previous post is that most assays
        focus on a specific virus. To check for all known
        deseases, one may end up performing several tests (unless
        some company comes out with an array of assays on a
        single solid phase). If VITX's product can universally
        eliminate any type of virus (I have no idea if they can)
        then it would again be a peace if mind and a liability
        thing. which goes beyond cost. I would like to know just
        how well the PLAS-D (or whatever its called)
        treatment works.

        As for the earning estimates, I
        would presume that you can find that in the Yahoo
        section under "research", which gives the estimates by
        the few analysts that follow this company.

        One
        thing I would like to know is that if light is so
        destructive to the viruses, cant one just store the blood
        bags in a lighted storage for some time to kill off
        the viruses or does this also decimate the blood
        cells as well?

 

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.